| Nov 7 |
Dare Bioscience (DARE) Upgraded to Buy: Here's What You Should Know
|
| Nov 7 |
Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024
|
| Oct 30 |
Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
|
| Oct 23 |
Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
|
| Oct 21 |
Daré Bioscience enters into $15M stock purchase agreement
|
| Oct 21 |
Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
|
| Aug 26 |
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
|
| Aug 13 |
Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
|
| Aug 13 |
Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript
|
| Aug 12 |
Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates
|
